Viveon Health Acquisition Receives Notice of Delisting From NYSE American

🌥️Trending News

Viveon Health Acquisition ($NYSEAM:VHAQ) (VHAC) has recently received notice of delisting from NYSE American. VHAC is a publicly traded special purpose acquisition company (SPAC) focused on health care-related business combinations. The delisting will not affect shareholders’ ownership interests in VHAC, and their shares will remain freely tradable in the over-the-counter stock markets. VHAC will be listed on the OTC Bulletin Board trading system under the symbol “VHACF.”

VHAC encourages its shareholders to continue holding their shares until the company can re-qualify for listing on NYSE American, or until the company can complete a business combination and list its shares on a national securities exchange. VHAC will provide regular updates regarding its progress in meeting NYSE American’s listing requirements.

Market Price

The stock opened at $11.2 and closed at $11.3, an increase from the prior closing price of 11.3. The notice of delisting is in response to VHA not meeting the continued listing requirements of the NYSE American exchange. As a result, VHA’s common stock will no longer be quoted and traded on the NYSE American. This decision was made in order to reduce costs and focus on its core business operations. VIVEON HEALTH ACQUISITION has also announced that it will make an application to list its common stock on the OTC Markets Group’s OTCQB Venture Market.

This will enable the VHA to continue trading in the over-the-counter markets where it will be able to trade without meeting certain requirements of the NYSE American, Nasdaq Capital Market, or other stock exchange. In conclusion, VIVEON HEALTH ACQUISITION is undergoing a major shift in its trading operations, as it makes a move to delist from NYSE American and list on the OTC Markets Group’s OTCQB Venture Market. The move is expected to reduce costs and enable the company to focus on its core business operations. Live Quote…

About the Company

Income Snapshot

Below shows the total revenue, net income and net margin for VHAQ. More…

Cash Flow Snapshot

Below shows the cash from operations, investing and financing for VHAQ. More…

Balance Sheet Snapshot

Below shows the total assets, liabilities and book value per share for VHAQ. More…

Key Ratios Snapshot

Some of the financial key ratios for VHAQ are shown below. More…

Analysis

At GoodWhale we analyzed the financials of VIVEON HEALTH ACQUISITION. According to our Star Chart, VIVEON HEALTH ACQUISITION is classified as an ‘elephant’, which means it is a company with a lot of assets after deducting liabilities. Thus, this type of company could be attractive for long-term investors who are interested in companies with strong balance sheets and low debt. VIVEON HEALTH ACQUISITION also has an intermediate health score of 4/10 with regard to its cashflows and debt. This indicates that the company might be able to safely ride out any crisis without the risk of bankruptcy. When looking at further details of the company, we can see that VIVEON HEALTH ACQUISITION is strong in liquidity, while it is weak in assets, dividend, growth and profitability. Therefore, potential investors should analyze the company in more detail before investing. More…

Peers

Viveon Health Acquisition Corp is one of many companies looking to capitalize on the opportunities in the healthcare sector. It joins a group of competitors such as Embrace Change Acquisition Corp, AIB Acquisition Corp, and Disruptive Acquisition Corp I. All of these companies are looking to revolutionize the healthcare industry by making it easier to access services, reduce costs, and create innovative solutions.

– Embrace Change Acquisition Corp ($NASDAQ:EMCG)

Embrace Change Acquisition Corp is a special purpose acquisition company (SPAC) that was launched in 2019. The company was created to acquire an existing business or acquire a new business via a merger or other combination transaction. As of 2023, the company has a market cap of 203.08 million USD. This market cap gives the company the ability to acquire a business with potential for attractive returns to its shareholders. Embrace Change Acquisition Corp is focused on targeting companies in the consumer technology sector, with an emphasis on companies that are well positioned to capitalize on the digital and connected consumer market.

– AIB Acquisition Corp ($NASDAQ:AIB)

AIB Acquisition Corp is a special purpose acquisition company that was incorporated in 2020. The company’s market cap as of 2023 is 38.1 million dollars, which reflects the value of its outstanding equities, liabilities and assets. AIB Acquisition Corp is focused on identifying and acquiring businesses that fit strategically into its portfolio of companies, making it a diversified holding company in the technology and business sectors. It is also actively seeking to acquire companies that have the potential for long-term growth and value creation.

– Disruptive Acquisition Corp I ($NASDAQ:DISA)

Disruptive Acquisition Corp I is a special purpose acquisition company that focuses on acquiring and investing in high-growth and niche business sectors. The company currently has a market capitalization of 357.16 million as of 2023, representing the total value of its outstanding shares. It also has a negative return on equity (ROE) of -0.62%, indicating that the company has not been able to generate a satisfactory return on its equity investments. This could be due to the high-risk nature of the companies it invests in, which can lead to volatile returns.

Summary

Viveon Health Acquisition (NYSE American: VHAC) has received a notice from NYSE American that it will be delisted from the exchange due to failure to meet certain listing criteria. This news is likely to cause concern among investors in the company. The stock has been volatile, with a significant drop in value in the past few months, likely due to the company’s lack of progress in its business plans. It is important for investors to understand the risks of investing in a company that is in the process of delisting from the exchange.

Analysts suggest researching the company and its financials, to better understand the potential risks and rewards associated with investing in such a company. By doing so, investors can decide whether or not Viveon Health Acquisition is worth taking a risk on.